Harrison.ai Raises $112M in Series C Funding

Harrison.ai, an Australian healthtech startup, has raised $112 million in a Series C funding round led by Horizons Ventures, Aware Super, and ECP Asset Management, bringing its total funding to over $240 million. The company, co-founded by Aengus and Dimitry Tran, uses AI to improve diagnostic accuracy in medical imaging, such as CT scans and X-rays, through its products Annalise.ai and Franklin.ai. These tools are designed to assist radiologists and pathologists by quickly identifying clinical findings, thus enhancing diagnostic accuracy and addressing the global shortage of skilled clinicians. Harrison.ai plans to use the new funds to expand into the U.S. and other key markets, aiming to alleviate disparities in access to advanced diagnostic services. The startup's AI technology is operational in over 1,000 healthcare facilities across 40 countries, with significant regulatory clearances including 12 from the FDA in the U.S. This funding round also included participation from new investors like the National Reconstruction Fund Corporation and Wollemi Capital Group.